Bron 1
Chicca, A., Caprioglio, D., Minassi, A., Petrucci, V., Appendino, G., Taglialatela-Scafati, O., & Gertsch, J. (2014). Functionalization of β-caryophyllene generates novel polypharmacology in the endocannabinoid system. ACS chemical biology, 9(7), 1499-1507.
Bron 2
Bahi A, Al Mansouri S, Al Memari E, Al Ameri M, Nurulain SM, Ojha S. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiol Behav. 2014 Aug;135:119-24. doi: 10.1016/j.physbeh.2014.06.003. Epub 2014 Jun 13. PMID: 24930711.
Bron 3
Peng J, Fan M, An C, Ni F, Huang W, Luo J. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic Clin Pharmacol Toxicol. 2022 Apr;130(4):439-456. doi: 10.1111/bcpt.13710. Epub 2022 Feb 6. PMID: 35083862.
Bron 4
Brito LF, Oliveira HBM, das Neves Selis N, E Souza CLS, Júnior MNS, de Souza EP, Silva LSCD, de Souza Nascimento F, Amorim AT, Campos GB, de Oliveira MV, Yatsuda R, Timenetsky J, Marques LM. Anti-inflammatory activity of β-caryophyllene combined with docosahexaenoic acid in a model of sepsis induced by Staphylococcus aureus in mice. J Sci Food Agric. 2019 Oct;99(13):5870-5880. doi: 10.1002/jsfa.9861. Epub 2019 Jul 11. PMID: 31206687.